Mondelez International, Inc. (MDLZ) Stock Analysis

46.0/100
Hold Not Halal Consumer Defensive
Price $64.70
Market Cap $79.53B
52-Week Change +2.03%

Is MDLZ a good investment?

Mondelez International, Inc. (MDLZ) has a Plutrex AI rating of 46.0/100 as of August 22, 2026, indicating a Hold consensus. The stock is not classified as halal-compliant. Key strength: Operating margin of 21.98% leads the Food Confectioners peer group by 22% above the industry average of 18.01%, demonstrating genuine pricing power and cost discipline that peers cannot replicate — the strongest operational efficiency metric in the competitive set. Main concern: PEG ratio of 2.60 is 43.5% above the industry average of 1.81 while 5-year forward EPS growth of 7.35% is 43.4% below the peer average of 12.99% — MDLZ is simultaneously the most expensively valued and slowest-growing stock in the peer group on a growth-adjusted basis, the worst risk/reward combination in the competitive set; analyst consensus target of $69.05 implies only 7.1% upside, providing minimal margin of safety.

Investment Summary

Mondelez International (MDLZ) at $64.45 remains a Hold — a quality consumer staples franchise priced well above its growth-adjusted intrinsic value. The core problem is unchanged: PEG ratio of 2.60 (43.5% above the industry average of 1.81) while 5-year forward EPS growth of 7.35% is 43.4% below the peer average of 12.99%. The P/E of 23.53x is reasonable in isolation but unjustifiable against 7.3% long-term earnings growth — fair-value P/E for this growth rate is 11–15x, implying 35–50% overvaluation on a growth-adjusted basis. The analyst consensus target of $69.05 offers only 7.1% upside from current price, a thin margin of safety. On the positive side, Q2 2026 delivered 4.1% net revenue growth and 2.2% organic growth, FCF of $2.25B is robust, and operating margin of 21.98% leads the peer group by 22%. News sentiment is strongly positive at 94.7/100 with 12 of 15 articles positive, reflecting a Q2 beat and raised 2026 guidance. However, positive news is already reflected in the current price — the stock has risen 1.3% since the prior report. New buyers should wait for the $54.00–$57.50 entry zone; existing holders should hold given strong FCF and dividend support.

Key Strengths

Key Concerns

Plutrex 10-Factor AI Breakdown

Financial Health
48/100
Growth Potential
25/100
Valuation
20/100
Profitability
52/100
Debt Management
55/100
Analyst Sentiment
60/100
Technical Momentum
45/100
Insider Confidence
50/100
News Sentiment
87/100

Fundamental Analysis

MDLZ's fundamentals present a bifurcated picture. Profitability is operationally strong: gross margin 35.0% (in line with peer average 35.89%), operating margin 22.0% (22% above peer average 18.01%), but net margin of only 8.86% (22% below peer average 11.36%) reveals heavy below-the-line charges from interest expense on D/E of 0.64 (11.7% above peer average 0.57). ROE of 13.31% is 29.3% below the peer average of 18.82% — peers generate far superior equity returns despite MDLZ's operational efficiency edge. Growth is the critical weakness: YoY EPS growth of -8.4% (recent deterioration), next-year EPS growth of 10.3% (22.8% below peer average 13.39%), and 5-year EPS CAGR of 7.35% (43.4% below peer average 12.99%). Revenue growth of 4.1% is modest but slightly above peer average 3.37%. Valuation is the primary concern: P/E 23.53x vs. peer average 25.60x (8.1% discount on headline PE) but PEG 2.60 vs. peer average 1.81 (43.5% premium on growth-adjusted basis) — MDLZ is the most expensively valued stock in the peer group relative to its growth. FCF of $2.25B is the standout financial health positive, providing genuine intrinsic value floor and supporting the $1.716B cash balance. Financial health score 45/100 reflects leverage concerns limiting balance sheet flexibility.

News Sentiment

Mondelez International is showing signs of a business comeback — but Wall Street isn't sure the stock price reflects that yet. The maker of Oreo cookies, Cadbury chocolate, and Ritz crackers reported solid second-quarter 2026 results, with net revenues growing 4.1% and organic revenue up 2.2%, driven by steady consumer demand for chocolates and biscuits even as inflation-weary shoppers watch their spending. The headline 'MDLZ Q2 Sales Beat and Higher 2026 Growth View Put Margins in Focus' captures the central tension: the company beat expectations and raised its full-year growth outlook, but investors are now asking whether profitability can keep pace. That question is echoed in 'Is MDLZ Worth Buying as Growth Improves but Valuation Stays Rich?' — a headline that perfectly summarizes the bull-bear debate. Analysts are watching whether the organic growth momentum highlighted in 'Can Mondelez's Organic Growth Momentum Continue Through 2026?' can be sustained into the second half, particularly given chocolate category softness that could pressure margins. On the brand front, 'For the First Time Ever, the OREO Brand Lets Fans Determine Which of Three New Flavors Launches' signals smart consumer engagement that reduces new product launch risk. And for income investors, 'Mondelez: This Dividend Stock Still Has Room To Run' highlights the company's reliable cash generation. The bottom line: Mondelez is executing well operationally, but at current prices, much of the good news is already baked in.

Risk Assessment

PRIMARY RISK: Valuation compression. At PEG 2.60 with 7.35% long-term EPS growth, any disappointment in the 10.3% next-year EPS recovery (driven by margin expansion rather than revenue acceleration) could trigger a de-rating toward the peer average PEG of 1.81, implying a fair-value price of approximately $45–$50 — a 22–30% downside from current levels. SECONDARY RISK: Chocolate category weakness (noted in business impact analysis) could pressure the key product line that drives organic growth, undermining the 2.2% organic growth trajectory. TERTIARY RISK: Currency headwinds in emerging markets (geographic diversification is a strength but also an FX exposure) could compress reported revenue growth below the 4.1% level. MITIGATION: Strong FCF of $2.25B provides a genuine floor — the company can sustain its dividend and buyback program even in a mild earnings miss scenario. The $54.00–$57.50 entry zone provides a 11–16% discount to current price that compensates for the growth/valuation mismatch and improves risk/reward to approximately 3:1 from the entry midpoint of $55.75 to target 1 of $69.05 (23.9% upside) vs. stop loss of $51.50 (7.6% downside). STOP LOSS at $51.50 represents approximately 10% below the entry midpoint and is set below key technical support, limiting downside to a manageable level.

Related Halal Stocks

Related Stocks

Frequently Asked Questions

Is MDLZ a halal stock?

No, Mondelez International, Inc. (MDLZ) is currently not classified as halal by AAOIFI criteria.

What is Plutrex's AI rating for MDLZ?

Mondelez International, Inc. (MDLZ) has a Plutrex AI rating of 46.0/100 with a Hold consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.

Is MDLZ a good investment?

According to Plutrex AI, MDLZ has a Hold rating (46.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.

How can I invest in MDLZ?

US stocks like MDLZ can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.

What are the main risks of investing in MDLZ?

Plutrex AI identifies the main risks for MDLZ by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.

Chat with Plutrex AI about MDLZ

Ask anything about this stock and get an instant AI-powered answer — free, no signup required.

Open MDLZ in Plutrex